Efficacy of metformin, ivermectin, fluvoxamine for COVID-19
Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…
FDA: Class I recall of Intera 3000 Hepatic Artery Infusion Pump
Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…
Moral distress in healthcare providers working in safety net practices during COVID-19
Editor's Note This study led by researchers at the University of North Carolina School of Medicine, Chapel Hill, finds that nearly 72% of healthcare providers in US safety net practices experienced either mild or intense levels of moral distress during the first year of COVID-19 because of issues with patient…
ECRI announces guidance on supporting healthcare worker resilience
Editor's Note ECRI, on August 29, announced its new guidance on “Supporting Resilience in Healthcare Workers” that was published on August 15 for its members. With a new focus on protecting healthcare workers against burnout and other behavioral health issues, new strategies for protecting and maintaining resilience have emerged, ECRI…
Free at-home COVID-19 tests distribution to end this Friday
Editor's Note On Friday, September 2, the US government will stop giving away free at-home COVID-19 tests because of insufficient congressional funds, according to a senior Biden administration official, NBC News August 28 reports. The White House official said unless there is a surprise round of funding from Congress, the…
Moderna sues Pfizer and BioNTech for COVID-19 vaccine patent infringement
Editor's Note On Friday, August 26, the vaccine manufacturer Moderna sued Pfizer and the German drugmaker BioNTech, accusing its competitors of copying technology that Moderna had developed prior to the pandemic, The New York Times August 26 reports. The patent infringement claims could result in a protracted and expensive legal battle…
Effect of aspirin vs enoxaparin on VTE after total hip, knee arthroplasty
Editor's Note This study (CRISTAL randomized trial) from Australia finds that aspirin compared with enoxaparin resulted in significantly higher rates of venous thromboembolism (VTE) after total hip or knee arthroplasty. This cluster-randomized, crossover trial included 9,711 patients in 31 hospitals in Australia—5,675 in the aspirin group and 4,036 in the…
FDA: Class I recall of Medtronic’s HeartWare HVAD system batteries
Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…
HHS releases two reports on long COVID-19 research, support
Editor's Note On August 3, as directed by President Joe Biden in a briefing room release in April 2022, when he tasked the Department of Health and Human Services (HHS) “to coordinate the federal response to the long-term health effects of COVID-19,” as reported by OR Manager, HHS released a national…
FBI warns healthcare professionals about fraud scheme
Editor's Note The FBI on August 22 warned healthcare workers of ongoing fraud schemes where scammers impersonate law enforcement and government officials in an effort to extort money or steal personally identifiable information (PII), Healthcare Purchasing News August 24 reports. By researching a medical practice’s website or social media, scammers…
Free Daily News
- Study: Post-laparotomy incisional negative pressure wound therapy fails to reduce infection risk
- FDA announces multiple Class 1 recalls
- Study: ERAS protocol reduces opioid use after cardiac surgery
- Study: Prehabilitation reduces surgical complications, speeds recovery
- Commentary: Studies show how surgeon decisions follow the money
- Proposed HIPAA updates would improve cybersecurity, increase costs for healthcare providers
- Study: EMR data can enhance hand hygiene compliance, infection prevention
- Study: Machine learning model improves perioperative pain assessment
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin